[Pubmed] Myasthenia gravis after allogeneic hematopoietic stem cell transplantation: Two case reports and literature rev
Posté : 02 déc. 2024 12:00
Zhonghua Xue Ye Xue Za Zhi. 2024 Oct 14;45(10):956-959. doi: 10.3760/cma.j.cn121090-20240311-00089.
ABSTRACT
The onset of myasthenia gravis (MG) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) seriously threatens the survival of patients, since it is acute, and is prone to rapid progression. Two patients with acute myeloid leukemia (AML), who had undergone allo-HSCT developed shortness of breath, and gradually developed cervical weakness and dyspnea. The acetylcholine receptor (AChR) antibody and neostigmine test enabled the diagnosis of MG. The condition of the patients improved after treatment with pyridostigmine bromide, glucocorticoids and rituximab.
PMID:39622761 | DOI:10.3760/cma.j.cn121090-20240311-00089
Source: https://pubmed.ncbi.nlm.nih.gov/3962276 ... t9+e462414